CD40LG and marginal zone lymphoma: In clinical practice, MYD88L265P aids in supporting the diagnosis of WM and helps differentiate from other IgM-secreting lymphoid malignancies, such as marginal zone lymphoma (MZL) and IgM multiple myeloma (MM), where it is less frequently mutated or absent, respectively.